课题基金 / 基金详情

A 3D microperfusion model of autosomal dominant polycystic kidney disease

A 3D microperfusion model of autosomal dominant polycystic kidney disease
常染色体显性多囊肾病的 3D 微灌注模型
批准号:
8779922
负责人:
Erica Palma Kimmerling
金额:
$4.27万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2016-08-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):常染色体显性多囊肾病(ADPKD)是一种单基因疾病,导致双侧局灶性囊肿的发展,最终导致肾功能衰竭,需要肾脏替代治疗,如透析或移植。考虑到该疾病在美国影响超过60万人,ADPKD患者约占所有肾脏替代治疗的4%。尽管该疾病与PKD1(85%的病例)或PKD2(15%的病例)突变有关,但在囊肿形成的发病和疾病严重程度方面,患者之间存在很大的差异。由于对疾病发病机制的了解有限,目前还没有针对ADPKD的特异性治疗方法,并且目前缺乏能够阐明囊肿发展背后机制的体外组织模型。本项目的目标是开发ADPKD的三维微灌注模型,作为研究细胞发生的一种全新方法。所提出的方法是组织工程和微流体学的独特结合,可以研究囊肿形成对机械感觉线索的反应,如流体流动,这在当前的方法中是无法实现的。该系统内的流体流动可用于评估组织对与肾损伤相关的血流变化的反应,并引入模拟肾修复的条件。为了实现这些目标,将开发一种定制的3D灌注系统,该系统由多孔丝蛋白支架中的微尺度通道组成,以提供适当的细胞环境(目的1a)。将开发的PKD1可控敲低的3D体外人肾小管ADPKD疾病模型纳入灌注系统,在灌注和静态条件下比较正常和病变组织(aim 1b)。将描述正常和病变组织对基于损伤的流体流动变化和随后的修复刺激的反应(目标2)。据推测,在ADPKD模型中,由于mTOR和STAT6等相关通路的异常激活,模拟损伤的力最终会导致细胞增殖和囊肿形成的增加。对细胞途径和与囊肿形成相关的外力的进一步了解将最终有助于开发针对该疾病的靶向治疗方法。本提案的结构要求同时进行多种技能的培训,包括细胞和分子生物学,生物材料设计和工程,生物反应器设计和实施以及成像。卡普兰实验室研究的多样性为实现上述建议和期望的培训提供了合适的环境。
英文摘要
DESCRIPTION (provided by applicant): Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic disorder that causes the development of bilateral focal cysts which ultimately result in renal failure and the need for renal replacement therapy such as dialysis or transplantation. Considering the disease affects over 600,000 people in the United States patients with ADPKD account for approximately 4% of all renal replacement therapy. Although the disease is associated with a mutation of either PKD1 (85% of cases) or PKD2 (15% of cases), there is a high level of variability between patients with respect to onset of cyst formation and disease severity. Due to a limited understanding of the disease pathogenesis there are no specific treatments for ADPKD and there is currently a lack of in vitro tissue models capable of elucidating the mechanisms behind cyst development. The goal of this project is to develop a 3D microperfusion model of ADPKD as a completely novel approach for investigating cytogenesis. The proposed methodology is a unique combination of tissue engineering and microfluidics which enables studies of cyst formation in response to mechanosensory cues, such as fluid flow, that is unattainable in current approaches. Fluid flow within this system can be used to evaluate the response of the tissue to changes in flow associated with renal injury and to introduce conditions mimicking renal repair. To achieve these goals a custom 3D perfusion system consisting of a microscale channel in a porous silk protein scaffold will be developed to provide the appropriate cell environment (aim 1a). A 3D in vitro human kidney tubule ADPKD disease model developed to have a controllable knockdown of PKD1 will be incorporated into the perfusion system for a comparison of normal and diseased tissues under perfusion and static conditions (aim 1b). The response of the normal and diseased tissues to injury based changes in fluid flow and subsequent repair stimulation will be characterized (aim 2). It is hypothesized that the forces mimicking injury will ultimately result in increased cell proliferation and cyst formation in the ADPKD model as the result of aberrant activation of affiliated pathways such as mTOR and STAT6. An increased understanding of the cellular pathways and external forces associated with cyst formation will ultimately assist in the development of targeted treatments for the disease. The structure of this proposal requires concurrent training in a diverse skill set including cell and molecular biology, biomaterials desig and engineering and bioreactor design and implementation and imaging. The diversity of research within the Kaplan lab provides the appropriate environment for pursuing the above proposal and desired training.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金